GlassScriptPhysician profile
Sharai Correll Amaya
NPI 1437279254
$9,206.10
in general payments reported to CMS, 2019-2025
18 companies · $449 in 2025
The $449 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.29 · 2022: $122 · 2023: $1,084 · 2024: $7,535 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,614 · Travel and Lodging: $2,715 · Food and Beverage: $1,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,614.36 |
| Travel and Lodging | $2,714.70 |
| Food and Beverage | $1,738.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,135.87 | 2023-2025 | Da Vinci Surgical System |
| Applied Medical Resources Corporation | $970.13 | 2022-2023 | Gelpoint V-Path |
| Astellas Pharma US INC | $232.71 | 2024-2025 | Veozah |
| Abbvie INC. | $128.09 | 2021-2025 | Lo Loestrin Fe |
| Biogen, INC. | $125.33 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $119.68 | 2023-2025 | |
| Minerva Surgical, INC | $108.33 | 2022-2025 | |
| Organon LLC | $101.11 | 2024-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $56.26 | 2023-2024 | |
| Millicent US INC | $40.31 | 2025 | Intrarosa, Femring |
| Shield Therapeutics INC | $39.85 | 2025 | |
| Pfizer INC. | $36.08 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $35.19 | 2024 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $17.36 | 2023 | Exparel |
| Medtronic, INC. | $16.97 | 2024 | V-Loc 180 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.93 | 2025 | Slynd |
| Hologic Sales and Service, LLC | $13.97 | 2025 | Aptima, Thinprep 2000 Processor |
| Glaxosmithkline, LLC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharai Amaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.